SHERLOCK Biosciences in the News.
News Overview
Read about Sherlock’s work to revolutionize molecular diagnostics and bring highly accurate, rapid, and affordable testing to the world.
April 23, 2019
Sherlock Biosciences Announces Close of Series A Round with Additional Investment Led by Northpond Ventures and Baidu VenturesMarch 21, 2019
Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering BiologyApril 13, 2017
- STAT News
CRISPR cousin SHERLOCK may be able to track down diseases, scientists sayApril 13, 2017
- Washington Post
A new CRISPR breakthrough could lead to simpler, cheaper disease diagnosisApril 27, 2018
- Science
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6August 05, 2016
- Science
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effectorIf you would like to discuss how our platform can be put to use in new ways, send us an email at partners@sherlock.bio.
Partner with us